Audiologists’ perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey

PURPOSE: Platinum-based chemotherapies used to treat many types of cancers are ototoxic. Ototoxicity management (OtoM) to mitigate the ototoxic outcomes of cancer survivors is recommended practice yet it is not a standard part of oncologic care. Although more than 10,000 patients each year are treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Konrad-Martin, Dawn, Polaski, Rachel, DeBacker, J. Riley, Theodoroff, Sarah M., Garinis, Angela, Lacey, Cecilia, Johansson, Kirsten, Mannino, Rosemarie, Milnes, Trisha, Hungerford, Michelle, Clark, Khaya D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892665/
https://www.ncbi.nlm.nih.gov/pubmed/36729345
http://dx.doi.org/10.1007/s11764-022-01316-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892665/
https://www.ncbi.nlm.nih.gov/pubmed/36729345
http://dx.doi.org/10.1007/s11764-022-01316-7

Ejemplares similares